Agios Pharma (AGIO) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Agios Pharma (AGIO) PT Raised to $90 at RBC Capital
May 7, 2018 7:39 AM EDTRBC Capital raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 (from $88.00) while maintaining an Outperform rating.
Analsyt Kennen MacKay said came away from the R&D day more positive towards the company's internal pipeline and R&D engine. AGIO detailed the broad IDH... More
